Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,575 | 92 | 96.6% |
| Education | $89.99 | 1 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $526.27 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $485.41 | 30 | $0 (2023) |
| Medtronic, Inc. | $214.15 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $199.31 | 7 | $0 (2024) |
| HealthTronics Mobile Solutions, LLC | $159.08 | 2 | $0 (2018) |
| UROGEN PHARMA, INC. | $143.20 | 2 | $0 (2021) |
| Endocare, Inc. | $115.00 | 1 | $0 (2017) |
| Coloplast Corp | $112.49 | 1 | $0 (2017) |
| AbbVie Inc. | $104.21 | 7 | $0 (2020) |
| PFIZER INC. | $87.04 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $348.92 | 5 | Medtronic, Inc. ($214.15) |
| 2023 | $402.89 | 20 | Janssen Biotech, Inc. ($225.18) |
| 2022 | $265.24 | 7 | AngioDynamics, Inc. ($146.02) |
| 2021 | $326.18 | 4 | AngioDynamics, Inc. ($168.83) |
| 2020 | $42.67 | 3 | Ferring Pharmaceuticals Inc. ($14.99) |
| 2019 | $270.44 | 17 | Janssen Biotech, Inc. ($80.57) |
| 2018 | $371.52 | 16 | HealthTronics Mobile Solutions, LLC ($159.08) |
| 2017 | $637.26 | 21 | Astellas Pharma US Inc ($138.71) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $182.11 | General |
| 10/11/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $32.04 | General |
| 09/26/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 08/22/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Oncology | ||||||
| 04/23/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $88.48 | General |
| Category: OS | ||||||
| 12/16/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: Immunology | ||||||
| 11/30/2023 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $122.94 | General |
| Category: OS | ||||||
| 11/29/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.33 | General |
| Category: Immunology | ||||||
| 11/20/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Immunology | ||||||
| 11/18/2023 | TELA Bio, Inc. | OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) (Device) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Surgical Mesh | ||||||
| 10/27/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Immunology | ||||||
| 10/27/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.76 | General |
| Category: Immunology | ||||||
| 10/24/2023 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $40.96 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: Immunology | ||||||
| 10/12/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Immunology | ||||||
| 10/11/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.14 | General |
| Category: Immunology | ||||||
| 09/21/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: Immunology | ||||||
| 09/13/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: Immunology | ||||||
| 08/17/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Immunology | ||||||
| 08/03/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Immunology | ||||||
| 07/17/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Immunology | ||||||
| 07/05/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Immunology | ||||||
| 06/19/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Immunology | ||||||
| 06/07/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.28 | General |
| Category: Immunology | ||||||
| 03/11/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 660 | 779 | $283,140 | $55,337 |
| 2022 | 13 | 626 | 764 | $219,955 | $56,127 |
| 2021 | 11 | 567 | 723 | $291,686 | $66,273 |
| 2020 | 17 | 772 | 864 | $435,607 | $88,930 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 188 | 228 | $29,640 | $11,501 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 112 | 129 | $25,800 | $9,820 | 38.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 109 | 159 | $130,380 | $9,473 | 7.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 83 | 83 | $25,020 | $8,731 | 34.9% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 34 | 34 | $20,400 | $3,382 | 16.6% |
| 55874 | Injection of biodegradable material next to prostate | Facility | 2023 | 23 | 23 | $12,880 | $2,874 | 22.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 39 | 39 | $8,190 | $2,638 | 32.2% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Facility | 2023 | 14 | 14 | $11,060 | $2,578 | 23.3% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Facility | 2023 | 12 | 15 | $9,750 | $1,700 | 17.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 24 | $3,360 | $1,520 | 45.2% |
| 55876 | Placement of device in prostate for radiation therapy | Facility | 2023 | 13 | 13 | $4,680 | $681.76 | 14.6% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 18 | 18 | $1,980 | $437.35 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 254 | 326 | $42,380 | $16,387 | 38.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 99 | 143 | $62,940 | $8,781 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 81 | 81 | $24,540 | $8,722 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 50 | 54 | $10,800 | $4,299 | 39.8% |
| 52240 | Destruction and/or removal of large growth of bladder using an endoscope | Facility | 2022 | 11 | 11 | $14,300 | $3,558 | 24.9% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Facility | 2022 | 18 | 24 | $15,730 | $3,173 | 20.2% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 26 | 26 | $15,600 | $2,579 | 16.5% |
| 55874 | Injection of biodegradable material next to prostate | Facility | 2022 | 18 | 18 | $10,080 | $2,247 | 22.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $4,895 | $1,713 | 35.0% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 11 | 15 | $9,180 | $1,526 | 16.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 13 | $3,380 | $1,358 | 40.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 21 | 21 | $4,450 | $1,349 | 30.3% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2022 | 13 | 21 | $1,680 | $435.12 | 25.9% |
About Dr. David Chen, M.D
Dr. David Chen, M.D is a Urology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841226081.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Chen, M.D has received a total of $2,665 in payments from pharmaceutical and medical device companies, with $348.92 received in 2024. These payments were reported across 93 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,575).
As a Medicare-enrolled provider, Chen has provided services to 2,625 Medicare beneficiaries, totaling 3,130 services with total Medicare billing of $266,667. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Philadelphia, PA
- Active Since 06/22/2006
- Last Updated 04/17/2018
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1841226081
Products in Payments
- NANOKNIFE (Device) $357.44
- TREMFYA (Drug) $322.43
- NanoKnife (Device) $168.83
- Endocare Cryocare System (Device) $159.08
- JELMYTO (Drug) $143.20
- ZYTIGA (Drug) $117.80
- Endocare Cryocare System (Medical Supply) $115.00
- PENILE RECONSTRUCTION (Device) $112.49
- XTANDI (Drug) $88.13
- Axumin (Drug) $85.41
- FIRMAGON (Drug) $56.22
- Lupron (Drug) $50.71
- ELIGARD (Drug) $46.24
- Xtandi (Drug) $45.73
- Erleada (Drug) $45.18
- Prolia (Biological) $41.10
- CYSVIEW (Drug) $40.96
- Lupron Depot (Drug) $40.34
- Myrbetriq (Drug) $29.43
- LITHOVUE (Device) $25.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Philadelphia
Dr. Daniel Eun, M.d, M.D
Urology — Payments: $382,660
Paul Chung, M.d, M.D
Urology — Payments: $251,745
Dr. Leonard Gomella, M.d, M.D
Urology — Payments: $248,176
Dr. Jay Simhan, M.d, M.D
Urology — Payments: $190,984
Robert Uzzo, Md02041967, MD02041967
Urology — Payments: $188,129
Dr. Edouard Trabulsi, M.d, M.D
Urology — Payments: $177,442